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A B S T R A C T  
Objective: To measure the effect of in vitro nicotine on reconstituted oral mucosal culture and to study its effect after 5 
minutes and 24 hours in normal healthy uninflammed oral mucosa. 
Material and Methods: This observational study was conducted at Department of Oral Pathology, Barts and London 
Queen Mary University London to measure the effect of in vitro nicotine on reconstituted oral mucosal model. The 
reconstituted human epithelium model was used and was supplied by Skin Ethic Laboratories, Nice, France. Cells 
viability was assessed by MTT assay. Working solutions (10μM, 100µM, 1mM, and 10mM) of nicotine were primed from 
2.5M stock solution (Sigma,UK). The effect of nicotine was studied after 5 minutes and 24 hours in normal healthy 
uninflamed oral mucosa. 
Results: It was found that that application of nicotine after 5 minutes and 24 hours’ treatment on uninflamed oral 
mucosal model and did not significantly affect the viability at all concentrations used. 
Conclusion: Nicotine did not show any effect on uninflamed mucosa and also had no momentous effect after 5 minutes 
and 24 hours respectively.  Further workup on proteomics and genomics is suggested to confirm our observations. 
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I n t r o d u c t i o n  
 
Tobacco use is regarded as a major cause morbidity and 
mortality and its extensive use has potentially significant 
and negative effects on oral and systemic health. The 
genus tobacco comes from a source named after Jean 
Nicot, a French ambassador that is being credited for the 
shipment of tobacco from Portugal to Paris in the year 
1560.1 The prevalence of smoking in countries like 
Western Europe, Australia, and the United States and the 
developing world is rising.2  Mackay and Eriksen in 2002 
reported that tobacco smoking has serious and adverse 
health consequences in all of the countries of the world 
irrespective of socio-economic status.3 People consume 
variety of tobacco goods which can be either chewed, 
smoked or sniffed.4 Products that are consumed could be 
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smoked such as cigarettes, cigars, pipe tobacco or can be 
consumed smokeless as snuff and chewing tobacco.5  
Cigarette smoking and tobacco usage are also associated 
with the development of other cancers, including cancer 
of the oesophagus, and the lungs.6 Fatal diseases such 
as respiratory heart disease, chronic obstructive lung 
disease, stroke, pneumonia, aortic aneurysm and 
ischaemic heart disease are also associated with 
smoking. Non-fatal diseases like a peripheral vascular 
disease, cataracts, and periodontal disease are also 
suggested to be associated with smoking.7 Both active 
and passive (environmental) cigarette smoking are the 
predisposing factors for cardiovascular morbidity and 
mortality.5 Nicotine addiction results in exposure to 
various carcinogens and other bioactive compounds 
present in tobacco.8 The risk of Renal cell carcinoma is 
increased with active smoking as compared to passive 
smoking.9 Smoking during pregnancy is also associated 
spontaneous abortion, ectopic pregnancy and low birth 
weight babies limb reduction defects and various other 
congenital defects in children. 
Nicotine (C10 H14 N2) is a naturally occurring alkaloid, 
obtained from the tobacco plant called Nicotina Tabacum 
present in the tobacco leaves and makes up about 5% of 
a tobacco plant by weight,10 and is highly addictive.11 It is 
now known that cigarette smoking is a result of addiction 
to nicotine and the amount of nicotine taken up by the 
people who use tobacco varies in each individual.12 
Nicotine, an important component of tobacco, is primarily. 
It is the addictive substance in tobacco and the main 
reason for the continuation of the use of tobacco-related 
products. Oral snuff and pipe tobacco contain 
concentrations of nicotine similar to cigarette tobacco, 
whereas cigar and chewing tobacco have only about half 
of the nicotine concentration of the cigarette tobacco. An 
average tobacco rod contains 10 to 14 mg of nicotine, and 
on average, about 1 to 1.5 mg of nicotine is absorbed 
systemically during smoking. It is suggested that 0.038-
0.217M nicotine concentration is present in smokeless 
tobacco.13 Cigarette smoking delivers rapid doses of 
nicotine into the brain, following each inhalation, 15-20 
minutes is its distribution half-life with a terminal half-life of 
two hours in the blood. Nicotine has a penetrating effect 
on brain neurochemistry causing activation of nicotinic 
acetylcholine receptors and releases dopamine in the 
nucleus accumbens.12 There are nicotinic acetylcholine 
receptors present in different regions of brain, autonomic 
ganglia, and the neuromuscular junction where from this 
nicotine acts and these are of two types, muscle and 
neuronal.13 Nicotine is a type of psychomotor stimulant, 
and helps smokers to calm down when they are under 
stress and enables them to work more effectively and with 
a higher concentration.12 
Nicotine is linked with many lesions inside the oral cavity.2 
It is recommended that nicotine could be correlated to the 
pathogenesis of oral white lesions.14 Carcinogens in 
tobacco smoke are responsible for the development of 
oral diseases and cancer. Nicotine adds to the risk factors 
for cancer when it is nitrosated and in turn, makes 
carcinogenic tobacco-specific nitrosamines.8 
In vivo studies revealed that topical application of 0.216M 
of nicotine to oral mucosa for two hours resulted in 
alterations in epithelium such as nuclear shrinkage and 
acantholysis.15 In a study conducted by Chen et-al it was 
evident that when 6% nicotine alone or in a combination 
of other tobacco-specific nitrosamines such as 0.01% 
NNN, 0.01% NNK was applied on hamster cheek pouch 
and gastric mucosal epithelium, it showed signs of 
hyperplasia, hyperkeratosis and also moderate 
dysplasia.16 They concluded that these changes may be 
associated with the development of squamous cell 
papillomas in animals. Du et al revealed that nicotine is 
more rapidly and completely absorbed through the 
mucosal membrane of non-keratinized regions like floor of 
the mouth that is the most permeable region, than through 
other parts of the mouth.17 Nicotine has also been shown 
to increase the permeability of oral mucosa to N-
nitrosonornicotine. Nitrosonornicotine is known to be a 
tobacco-specific carcinogen and is also suggested that 
0.2% nicotine significantly increases the permeability of 
oral mucosa to NNN and 2% nicotine causes a further 
increase to this permeability.17 
    M a t e r i a l  a n d  M e t h o d s  
This study was conducted at Department of Oral 
Pathology, Barts and London Queen Mary University of 
London. The reconstituted human epithelium model used 
in the study was supplied by SkinEthic Laboratories, Nice, 
France.  The study focused on the effects of nicotine on 
an uninflamed stratified epithelial layer, when applied for a 
 JIMDC  2017    184                           184 
period of 5 minutes and over 24 hours respectively. 
Tissue viability was assessed using a modified MTT 
assay. The reconstituted human epithelium is a three-
dimensional tissue culture model derived from a buccal 
carcinoma and obtained by culturing transformed oral 
keratinocytes (TR146). The cells were seeded and 
cultivated in a specific medium for 14 days. The 
consequential culture came out to be a stratified 
epithelium with 5-7 cell layers of epithelium. Model 
cultures were transferred into a new 24 well culture plates 
(Costar, UK) containing 500µl maintenance medium per 
well and incubated for 2 hours at 37ºC in 5% CO2 in a 
humidified atmosphere. The cultures were transferred to a 
new 24 well plate containing fresh media for all 
experiments. 
Working solution of nicotine + MTT ASSAY: Working 
solutions (10μM, 100µM, 1mM, and 10mM) of nicotine 
were set up from a 2.5M stock solution (Sigma,UK) and 
before use it was diluted in phosphate buffered saline 
(PBS). Viability assays were designed to quantify the 
proportion of cells that failed to survive under 
experimental conditions. In this study modified MTT assay 
was selected. The viability of exposed cultures was 
measured by the quantification of mitochondrial 
dehydrogenase activity using a modified MTT assay. MTT 
assay involves the use of a colour reaction as a measure 
of cell activity. MTT (3-(4, 5-dimethyl-thiazol-2-yl)-2, 5-
diphenyltetrazolium bromide) is a pale-yellow substrate, 
which is reduced to a dark blue insoluble formazan 
product when incubated with living cells. The amount of 
formazan uptake is measured using densitometry. At the 
end of the treatment period, the cultures were transferred 
into a new 24 well plate containing 300µl MTT solution 
(0.5mg/ml in PBS). The plate was wrapped in aluminium 
foil and incubated for 60 minutes at 37ºC in 5% CO2 in a 
humidified atmosphere. After incubation, the cultures 
were transferred to a new 24-well plate containing 750µl 
isopropyl alcohol per well and 750μl of isopropyl alcohol 
applied to the epithelial surface. The plate was carefully 
sealed with Parafilm®, to prevent evaporation, and then 
incubated for a further 2 hours at 37ºC to extract the 
formazan. The insert was then removed and any surface 
solution retained in the well. The plate was agitated gently 
in order to equilibrate the colour density. Expended 
cultures were discarded. Three 200µl aliquots from each 
well were transferred to a 96-well plate (Costar UK) and 
the optical density (OD) was determined using a Titertek 
Multiskan Plus plate reader. Epithelial viability was 
expressed as the absorbance at 570nm. The results for 
MTT assay were quoted as (mean ± standard deviation).  
R e s u l t s  
In this study, the tissue viability was assessed using a 
modified MTT assay. The results for MTT assay were 
quoted as (mean ± standard deviation) and it was 
observed that nicotine had no significant effect after 5 
minutes on the viability of uninflamed stratified epithelial 
layer at 10µM (88.98 ± 20.14), 100µM (77.12 ± 16.15), 
1mM (87.82 ± 12.28) and 10mM (97.70 ± 14.77) 
concentrations, when compared to PBS control (100 ± 
6.45), (Table 1).  
 
Moreover, nicotine had no significant effect after 24 hours 
on the viability of uninflamed stratified epithelial layer at 
10µM (111.72 ± 18.21), 100µM (110.10 ± 13.30), 1mM 
(96.90 ± 10.44) and 10mM (120.29 ± 13.99) 
concentrations, when compared to PBS control (100 ± 
12.78 %), (Table 2).  
Table 1: MTT results after 5 minutes nicotine treatment on 
uninflamed tissue (n=4) 
Treatment Viability 
Mean Standard 
deviation 
Nicotine (10µM) 88.98 20.14 
Nicotine (100µM) 77.12 16.15 
Nicotine (1mM) 87.82 12.28 
Nicotine (10mM) 97.70 14.77 
Phosphate buffered 
saline 
100 6.45 
Table 2: MTT results after 24-hour nicotine treatment on 
uninflamed tissue (n=4) 
Treatment Viability 
Mean Standard 
deviation 
Nicotine (10µM) 111.72 18.21 
Nicotine (100µM) 110.10 13.30 
Nicotine (1mM) 96.90 10.44 
Nicotine (10mM) 120.29 13.99 
Phosphate buffered 
saline 
100 12.78 
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Thus, results from MMT assay showed that application of 
nicotine after 5 minutes and 24 hours’ treatment on 
uninflamed oral mucosa did not significantly affect its 
viability at different concentrations used. 
D i s c u s s i o n  
Smoking has been associated with diseases of the lung, 
pulmonary airways, and oral cavity. Cytologic, genomic, 
and transcriptomic changes in oral mucosa correlate with 
oral preneoplasia, cancer, and inflammation (e.g. 
periodontitis). Most of the studies also suggest that 
nicotine contributes to inflammatory processes in the oral 
cavity, and plays a critical role in the development of oral 
white pre-malignant lesions, and could be associated with 
the development of cancer in different regions of the oral 
mucosa. Although this study provides an insight into the 
possible role of nicotine in the pathogenesis of tobacco-
related lesions in the oral cavity, there is a potential 
complexity which may limit the significance of the findings. 
In vivo, mucosa adjacent to nicotine is a stratified 
squamous epithelium and the results hence, presumes 
that nicotine has to saturate through epithelium to exert its 
effect. Various studies have been conducted to 
understand the direct effects of nicotine on a reconstituted 
stratified squamous epithelium in vitro.18  Recently, 
however, an in vitro reconstituted oral mucosa has 
become available. This system, thus, offers an alternative 
approach to evaluate the effect of nicotine on oral mucosa 
that may more closely reflect in vivo situation. 
The aim of this study was to explore the outcome of 
nicotine on an uninflamed reconstituted oral mucosa.  The 
results from viability studies suggested that nicotine 
treatment of uninflamed reconstituted oral mucosa after 5 
minutes and 24 hours had no significant effect on the 
viability of the cells, only a subtle change in membrane 
integrity and there were no morphological changes in the 
appearance of the epithelium. Chang YC et al in their 
study showed that 4mM nicotine dose caused significant 
morphological alterations of microtubules and vimentin 
filaments which then lead to atypical changes and 
vacuoles formation within the oral fibroblasts.19 In a study 
conducted by Schlage WK. et al, on oral organotypic 
epithelium models, after exposure to cigarette smoke 
(CS); CS was found to be associated with increased 
secretion of inflammatory mediators, induction of 
cytochrome P450s activity and overall weak toxicity. 
Using microarray technology, they also identified CS 
impact on xenobiotic metabolism-related pathways and 
alteration in inflammatory processes. They supported the 
use of oral organotypical tissue models for an impact 
assessment.20 Another study was conducted by Filippo 
Zanetti et al, in which human gingival epithelial 
organotypic cultures were repeatedly exposed (3 days) for 
28 min to CS. They also found a significant association of 
CS with proinflammatory mediators.21  
Chang YC et al had also linked higher doses of nicotine to 
be responsible for causing irreversible changes in the 
morphological appearance of the cells.19 In the present 
study, it was not possible to quantify the amount of 
mitrochondrial disruption by nicotine at the concentration 
range used. Further workup is required to confirm our 
observations. As no change in morphology was seen in 
these experiments, it might be better to look for electron 
microscopic changes. Moreover, DNA array technology 
can be used for effective detection of other cytokines 
release and any upregulated protein.22 Through the 
genomic study, the indirect identification of protein 
products could be achieved by simply comparing 
normal/untreated tissue with diseased/treated tissue. 
C o n c l u s i o n  
Nicotine concentration ranging from 10µM to 10mM had 
no significant effect on viability and morphology of the 
uninflamed oral mucosa. Short exposure to nicotine 
causes it to reduce while long-standing exposure caused 
it to amplify. 
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